XBiotech XBIT
NASDAQ XBIT
$2.00 -0.12 (-5.66%)
At close: Oct 19, 2026 · 4:00 PM EDT

XBiotech (XBIT) EPS (Basic) (2014 - 2026)

Updated

XBiotech's EPS (Basic) was -$0.22 in Q2 2026, compared with -$0.06 a year earlier.

Analysis

XBiotech (XBIT) EPS (Basic) (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, XBiotech's EPS (Basic) was -$1.36 through Jun 30, 2026; for FY2025, it was -$1.49.

  • In earlier years, EPS (Basic) was -$1.26 in FY2024, -$0.81 in FY2023, -$1.08 in FY2022 and -$0.58 in FY2021.
  • Quarterly EPS (Basic) has moved between -$0.88 (Q4 2025) and -$0.06 (Q2 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 7.95
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 2.30
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 2.04
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn -0.54
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 1.68
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 1.62
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 4.40
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn -8.44
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -0.04
10 XBiotech 60.98 Mn -474.44 Mn - -0.22
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.22
Dec 31, 2025 -0.88
Sep 30, 2025 -0.20
Jun 30, 2025 -0.06
Mar 31, 2025 -0.36
Dec 31, 2024 -0.34
Sep 30, 2024 -0.16
Jun 30, 2024 -0.43
Mar 31, 2024 -0.33
Dec 31, 2023 -0.15
Sep 30, 2023 -0.24
Jun 30, 2023 -0.29
Mar 31, 2023 -0.13
Dec 31, 2022 -0.11
Sep 30, 2022 -0.42
Jun 30, 2022 -0.38
Mar 31, 2022 -0.18
Dec 31, 2021 -0.22
Sep 30, 2021 -0.11
Jun 30, 2021 -0.17
API Access

XBiotech EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=XBIT&period=max&api_key=YOUR_API_KEY